Gasinska et al. found that higher nuclear Ki-67 expression (cut-off not specified) using the MIB-1 labeling index in pre-treatment biopsies was associated with an improved tumor response according to RECIST criteria (p = 0.023) after SCRT with a short break (<15 days) before surgery [18]. Here, MKI67 is linked to neoplasm.